Literature DB >> 2138007

Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis.

M E Jeurissen1, A M Boerbooms, L B van de Putte, M W Kruijsen.   

Abstract

Within one year three of 25 patients with rheumatoid arthritis treated with azathioprine 100 mg daily developed the following adverse reactions less than two weeks after starting treatment: patient one showed fever with chills, rash, and severe liver function abnormalities suggestive of cholestasis; the second patient had fever, nausea, diarrhoea, and moderately raised liver enzymes; the third patient showed very high fever and severe chills. In two patients the drug was rechallenged, with more rapidly arising and more severe symptoms. In one case raised liver enzymes persisted until seven months after discontinuation of azathioprine. Hypersensitivity reactions and hepatotoxicity of azathioprine are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138007      PMCID: PMC1003958          DOI: 10.1136/ard.49.1.25

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Azathioprine shock.

Authors:  E Rosenthal
Journal:  Postgrad Med J       Date:  1986-07       Impact factor: 2.401

2.  Serum IgA concentration and hepatotoxicity in rheumatoid arthritis treated with azathioprine.

Authors:  C Harvey; J S Dixon; H A Bird
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-20

3.  Azathioprine-induced shock.

Authors:  T Cunningham; D Barraclough; K Muirden
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

4.  Hypotension with oliguria: a side-effect of azathioprine.

Authors:  E C Keystone; R Schabas
Journal:  Arthritis Rheum       Date:  1981-11

5.  Hypersensitivity and jaundice due to azathioprine.

Authors:  M Davis; A L Eddleston; R Williams
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

6.  National Cooperative Crohn's Disease Study: adverse reactions to study drugs.

Authors:  J W Singleton; D H Law; M L Kelley; H S Mekhjian; R A Sturdevant
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

7.  Peliosis hepatis in recipients of renal transplants.

Authors:  C Degott; B Rueff; H Kreis; A Duboust; F Potet; J P Benhamou
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

8.  Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial.

Authors:  H Hamdy; R J McKendry; E Mierins; J A Liver
Journal:  Arthritis Rheum       Date:  1987-04

9.  Azathioprine toxicity in neuromuscular disease.

Authors:  J T Kissel; R J Levy; J R Mendell; R C Griggs
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

Review 10.  Azathioprine hypersensitivity. Case report and review of the literature.

Authors:  P A Saway; L W Heck; J R Bonner; J K Kirklin
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

View more
  10 in total

Review 1.  Leucocytoclastic vasculitis in a patient with azathioprine hypersensitivity.

Authors:  C G Beckett; P Hill; K R Hine
Journal:  Postgrad Med J       Date:  1996-07       Impact factor: 2.401

2.  Severe cholestasis due to azathioprine in Behcet's disease.

Authors:  Kadir Gisi; Murat Ispiroglu; Bulent Kantarceken; Hamide Sayar
Journal:  BMJ Case Rep       Date:  2019-03-31

3.  Using aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine.

Authors:  Vishal N Patel; David C Kaelber
Journal:  J Biomed Inform       Date:  2013-10-28       Impact factor: 6.317

Review 4.  Hepatotoxicity related to antirheumatic drugs.

Authors:  Guruprasad P Aithal
Journal:  Nat Rev Rheumatol       Date:  2011-01-25       Impact factor: 20.543

5.  Purine enzyme activities in recent onset rheumatoid arthritis: are there differences between patients and healthy controls?

Authors:  J N Stolk; A M Boerbooms; R A De Abreu; P J Kerstens; D G de Koning; R de Graaf; J Mulder; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

6.  Azathioprine-induced fever in autoimmune hepatitis.

Authors:  Tawfik Khoury; Jacob E Ollech; Shmuel Chen; Meir Mizrahi; Meir Shalit
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

Review 7.  Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.

Authors:  Alexander Teml; Elke Schaeffeler; Klaus R Herrlinger; Ulrich Klotz; Matthias Schwab
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 5.577

8.  Drug Hypersensitivity due to Azathioprine with Elevated Procalcitonin.

Authors:  Tania Ahuja; Frank R Chung; Tania Ruiz-Maya
Journal:  Case Rep Dermatol Med       Date:  2018-06-10

9.  A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus.

Authors:  Renato A da Costa; João A P da Rocha; Alan S Pinheiro; Andréia do S S da Costa; Elaine C M da Rocha; Rai C Silva; Arlan da S Gonçalves; Cleydson B R Santos; Davi do S B Brasil
Journal:  Molecules       Date:  2022-06-27       Impact factor: 4.927

10.  Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity.

Authors:  K Herrmann; S Schinke; E Csernok; F Moosig; J U Holle
Journal:  Open Rheumatol J       Date:  2015-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.